All Stories

  1. SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
  2. Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia
  3. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia
  4. Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
  5. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia
  6. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia
  7. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia
  8. Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome
  9. Overexpression of miR-216b : Prognostic and predictive value in acute myeloid leukemia
  10. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia
  11. Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia
  12. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies
  13. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia
  14. CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics
  15. GPX3methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
  16. Hypermethylation of DLX4 predicts poor clinical outcome in patients with myelodysplastic syndrome